ES2110375T1 - Agente antiinflamatorio para uso externo. - Google Patents

Agente antiinflamatorio para uso externo.

Info

Publication number
ES2110375T1
ES2110375T1 ES95933625T ES95933625T ES2110375T1 ES 2110375 T1 ES2110375 T1 ES 2110375T1 ES 95933625 T ES95933625 T ES 95933625T ES 95933625 T ES95933625 T ES 95933625T ES 2110375 T1 ES2110375 T1 ES 2110375T1
Authority
ES
Spain
Prior art keywords
external use
inflammatory agent
discoloration
safe
free
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES95933625T
Other languages
English (en)
Other versions
ES2110375T3 (es
Inventor
Satoru Miyata
Yasuaki Taniguchi
Kenji Masuda
Yoichi Kawamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helsinn Healthcare SA
Original Assignee
Helsinn Healthcare SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helsinn Healthcare SA filed Critical Helsinn Healthcare SA
Publication of ES2110375T1 publication Critical patent/ES2110375T1/es
Application granted granted Critical
Publication of ES2110375T3 publication Critical patent/ES2110375T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

AGENTE ANTIINFLAMATORIO DE USO EXTERNO, QUE CONTIENE NIMESULIDO COMO INGREDIENTE ACTIVO DISPERSO EN EL COMPONENTE BASE Y QUE ES BIEN ABSORBIBLE, SEGURO Y LIBRE DE DECOLORACION.
ES95933625T 1994-10-05 1995-10-05 Nimesulida para uso externo. Expired - Lifetime ES2110375T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26829394 1994-10-05

Publications (2)

Publication Number Publication Date
ES2110375T1 true ES2110375T1 (es) 1998-02-16
ES2110375T3 ES2110375T3 (es) 2001-12-01

Family

ID=17456521

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95933625T Expired - Lifetime ES2110375T3 (es) 1994-10-05 1995-10-05 Nimesulida para uso externo.

Country Status (16)

Country Link
US (1) US5837735A (es)
EP (1) EP0782855B1 (es)
KR (1) KR100339793B1 (es)
CN (1) CN1080561C (es)
AT (1) ATE205391T1 (es)
AU (1) AU701740B2 (es)
BR (1) BR9509183A (es)
CA (1) CA2201722A1 (es)
DE (2) DE782855T1 (es)
DK (1) DK0782855T3 (es)
ES (1) ES2110375T3 (es)
GE (1) GEP20002012B (es)
MX (1) MXPA97002401A (es)
PT (1) PT782855E (es)
UA (1) UA42795C2 (es)
WO (1) WO1996011002A1 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9601443A3 (en) * 1996-05-29 1999-03-29 Panacea Biotec Ltd Injectable analgetic pharmaceutical compositions for intramuscular use containing nimesulid, and process for producing them
IT1291278B1 (it) * 1996-07-05 1999-01-07 Errekappa Euroterapici S P A Preparazione farmaceutica a base di nimesulide per uso topico
CN1095661C (zh) * 1996-07-23 2002-12-11 灵药生物技术有限公司 含尼美舒利的抗炎和止痛的透皮使用的治疗组合物和它们的制备方法
RU2157689C2 (ru) * 1996-07-24 2000-10-20 Панацея Биотек Лтд. Фармацевтические композиции терапевтического антивоспалительного и болеутоляющего средства для местного нанесения и способ их получения
IT1289973B1 (it) * 1997-02-25 1998-10-19 Helsinn Healthcare Sa Sistemi gelificati di nimesulide per uso topico
IT1289972B1 (it) 1997-02-25 1998-10-19 Helsinn Healthcare Sa Formulazioni topiche di nimesulide in forma di sistemi a cristalli liquidi
IT1291895B1 (it) * 1997-04-24 1999-01-21 Errekappa Euroterapici S P A Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
IT1291997B1 (it) * 1997-05-26 1999-01-25 Schiena Michele Giuseppe Di Preparati-farmaceutici-topici-contenenti nimesulide
GB2340751B (en) 1998-08-12 2003-11-05 Edko Trading Representation Pharmaceutical compositions
FR2787322B1 (fr) * 1998-12-18 2002-10-18 Galderma Res & Dev Emulsion huile-dans-eau comprenant un agent actif micronise et un systeme emulsionnant approprie
WO2000072884A1 (en) * 1999-05-31 2000-12-07 Dinesh Shantilal Patel A novel formulation of n-(4-nitro-2-phenoxyphenyl)methanesulfonamide
US6702733B1 (en) 1999-07-01 2004-03-09 40 J's Llc Expanded clitoral sensitizing compounds with methods and apparatus for the delivery of these compounds
US6203796B1 (en) 1999-07-08 2001-03-20 Andreas D. Papaprodromou Oregano-based therapeutic composition
US8609412B2 (en) * 1999-08-05 2013-12-17 Regents Of The University Of Minnesota Mapc generation of lung tissue
IN191512B (es) * 2000-01-21 2003-12-06 Panacea Biotech
IT1318588B1 (it) * 2000-06-20 2003-08-27 Helsinn Healthcare Sa Uso della nimesulide nel trattamento di patologie dermatologiche.
NZ524252A (en) * 2000-07-20 2004-03-26 Lauras As Cox-2 inhibitors for treating HIV and AIDS
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US6479060B1 (en) 2001-09-04 2002-11-12 Healthpoint, Ltd. Elegant hydrogenated castor oil ointments
US20030059450A1 (en) * 2001-09-24 2003-03-27 Maibach Howard I. Method and topical formulation for treating skin conditions associated with aging
US6548545B1 (en) 2001-10-01 2003-04-15 40 J's Llc Treatment of interstitial cystitis using topical application of menthol and L-arginine
JP2007522079A (ja) * 2003-10-31 2007-08-09 エラン ファーマ インターナショナル リミテッド ニメスリド組成物
CZ2005214A3 (cs) * 2005-04-06 2006-10-11 Zentiva, A. S. Topická léková forma s obsahem nimesulidu
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
TR200906775A1 (tr) 2009-09-02 2011-03-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Nimesulid ve kas gevşetici kombinasyonları
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
ES2669306T3 (es) * 2010-11-02 2018-05-24 Teikoku Seiyaku Co., Ltd. Parche externo que contiene felbinaco
JP5826075B2 (ja) * 2012-03-08 2015-12-02 株式会社ナリス化粧品 化粧料
JP6213975B2 (ja) * 2012-09-13 2017-10-18 テイカ製薬株式会社 薬物含有超極細ファイバーおよびその利用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826845A (en) * 1969-02-08 1974-07-30 Sankyo Co Ointment base
US3840597A (en) * 1971-02-24 1974-10-08 Riker Laboratories Inc Substituted 2-phenoxy alkane-sulfonanilides
JPS55139313A (en) * 1979-04-16 1980-10-31 Ota Seiyaku Kk Gel cream composition comprising higher fatty acid ethanol amide, and drug containing it
WO1986000014A1 (en) * 1984-06-11 1986-01-03 Murray Weiner Topical compositions
IT1248475B (it) * 1990-05-22 1995-01-19 Angeli Inst Spa Composti di inclusione di nimesulide con ciclodestrine
EP0548088B1 (de) * 1991-07-16 1998-01-14 Schering Aktiengesellschaft Verfahren zur herstellung von mikronisierte wirkstoffe enthaltende halbfeste zubereitungen
JPH10257192A (ja) * 1997-03-14 1998-09-25 Fujitsu Ltd コールバック式受付処理方法及び装置

Also Published As

Publication number Publication date
AU701740B2 (en) 1999-02-04
GEP20002012B (en) 2000-04-10
DE69522696D1 (de) 2001-10-18
EP0782855A1 (en) 1997-07-09
AU3619295A (en) 1996-05-02
PT782855E (pt) 2001-12-28
MXPA97002401A (es) 2004-08-20
DK0782855T3 (da) 2001-12-27
ES2110375T3 (es) 2001-12-01
US5837735A (en) 1998-11-17
EP0782855A4 (en) 1997-09-10
EP0782855B1 (en) 2001-09-12
BR9509183A (pt) 1997-12-30
HK1001374A1 (en) 1998-06-19
CN1080561C (zh) 2002-03-13
UA42795C2 (uk) 2001-11-15
ATE205391T1 (de) 2001-09-15
KR970706016A (ko) 1997-11-03
CN1162262A (zh) 1997-10-15
DE782855T1 (de) 1998-05-28
WO1996011002A1 (en) 1996-04-18
KR100339793B1 (ko) 2002-07-18
DE69522696T2 (de) 2002-04-18
CA2201722A1 (en) 1996-04-18

Similar Documents

Publication Publication Date Title
BR9509183A (pt) Agente antiinflamatório para uso externo
PT698393E (pt) Agente de solubilizacao e preparacao para uso externo contendo o mesmo
ES2123323T3 (es) Asociacion de un compuesto con actividad antimicrobiana (por ejemplo lipoaminoacido n,n-octanoilglicina) y de un monoalquileter de glicerol y su uso como agente antimicrobiano.
ATE275393T1 (de) Feste dispersionen mit nitrataktiven wirkstoffen
ES8705762A1 (es) Procedimiento para preparar un agente analgesicamente activo a base de 2-amino-3-carboetoxiamino-6-(4-fluorobencilamino)-piridina y por lo menos un agente antiflogistico no esteroidal
FR2718018B1 (fr) Composition cosmétique et/ou dermatologique à support hydrophile et vitamine C mélangeables extemporanément.
BRPI9911849B8 (pt) composição espumante para a lavagem e o tratamento dos cabelos e/ou do couro cabeludo.
BR9405698A (pt) Composições tópicas para o olho compreendendo um derivado de beta-ciciodextrina e um agente terapêutico
BR9707588A (pt) Agente terapeutico para diabetes
FI964936A0 (fi) Bentsopyraaneja ja niiden käyttö terapeuttisina aineina
ES544787A0 (es) Preparaciones medicinales solidas
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
NL194456B (nl) Leidgestel voor gebruik bij de vervaardiging van halfgeleiderinrichtingen, voorzien van eerste en tweede positioneerorganen.
ES2059869T3 (es) Preparado farmaceutico que contiene piroxicam para uso topico.
ES2152315T3 (es) Xamoneline tartrato.
DE69021304D1 (de) Vorbeugendes und therapeutisches Mittel gegen Hepatitis.
TR199700409T1 (xx) Harici kullan�ma mahsus enflamasyon �nleyici madde.
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
RU96115480A (ru) Лекарственное средство, обладающее холелитолитическим действием
DE68920104D1 (de) Polyolefin-Zusammensetzungen und deren Anwendungen.
FI931159A7 (fi) Dosaerosoler, som innehåller som aktivt ämne flezelastin och med detta relaterade strukturer
SE8802040D0 (sv) New use
RU97122120A (ru) Средство для лечения системной красной волчанки
ES1015889Y (es) Mascarilla para uso medico-quirurgico.
SE8503513D0 (sv) Farmaceutiska och kosmetiska kompositioner, vilka som verksam bestandsdel innehaller acetyl-10-triacetoxi-1,8,9-antracen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 782855

Country of ref document: ES